Add article(s) associated with Tau family

Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation.

Babu J.R., Geetha T., Wooten M.W. et al
2005, J. Neurochem. (94) 192-203

Proteomic analysis of in vivo phosphorylated synaptic proteins.

Collins M.O., Yu L., Coba M.P. et al
2005, J. Biol. Chem. (280) 5972-5982

Large-scale characterization of HeLa cell nuclear phosphoproteins.

Beausoleil S.A., Jedrychowski M., Schwartz D. et al
2004, Proc. Natl. Acad. Sci. U.S.A. (101) 12130-12135

Tau gene (MAPT) sequence variation among primates.

Holzer M., Craxton M., Jakes R. et al
2004, Gene (341) 313-322

Tau gene delN296 mutation, Parkinson's disease, and atypical supranuclear palsy.

Oliva R., Pastor P.
2004, Ann. Neurol. (55) 448-449

Progressive supranuclear palsy and Parkinson's disease in a family with a new mutation in the tau gene.

Rossi G., Gasparoli E., Pasquali C. et al
2004, Ann. Neurol. (55) 448-448

Reversible paired helical filament-like phosphorylation of tau is an adaptive process associated with neuronal plasticity in hibernating animals.

Arendt T., Stieler J., Strijkstra A.M. et al
2003, J. Neurosci. (23) 6972-6981

Elevated gene expression levels distinguish human from non-human primate brains.

Caceres M., Lachuer J., Zapala M.A. et al
2003, Proc. Natl. Acad. Sci. U.S.A. (100) 13030-13035

A novel L266V mutation of the tau gene causes frontotemporal dementia with a unique tau pathology.

Kobayashi T., Ota S., Tanaka K. et al
2003, Ann. Neurol. (53) 133-137

An English kindred with a novel recessive tauopathy and respiratory failure.

Nicholl D.J., Greenstone M.A., Clarke C.E. et al
2003, Ann. Neurol. (54) 682-686

Tau (MAPT) mutation arg406trp presenting clinically with Alzheimer disease does not share a common founder in western Europe.

Rademakers R., Dermaut B., Peeters K. et al
2003, Hum. Mutat. (22) 409-411

Late-onset frontotemporal dementia with a novel exon 1 (Arg5His) tau gene mutation.

Hayashi S., Toyoshima Y., Hasegawa M. et al
2002, Ann. Neurol. (51) 525-530

An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype.

Poorkaj P., Muma N.A., Zhukareva V. et al
2002, Ann. Neurol. (52) 511-516

A novel tau mutation, S320F, causes a tauopathy with inclusions similar to those in Pick's disease.

Rosso S.M., Van, Herpen E. et al
2002, Ann. Neurol. (51) 373-376

Early-onset, rapidly progressive familial tauopathy with R406W mutation.

Saito Y., Geyer A., Sasaki R. et al
2002, Neurology (58) 811-813

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.

Strausberg R.L., Feingold E.A., Grouse L.H. et al
2002, Proc. Natl. Acad. Sci. U.S.A. (99) 16899-16903

Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).

Tsuboi Y., Baker M., Hutton M.L. et al
2002, Neurology (59) 1791-1793

Functional effects of tau gene mutations deltaN296 and N296H.

Yoshida H., Crowther R.A., Goedert M. et al
2002, J. Neurochem. (80) 548-551

Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes.

Connell J.W., Gibb G.M., Betts J.C. et al
2001, FEBS Lett. (493) 40-44

Familial frontotemporal dementia and parkinsonism with a novel N296H mutation in exon 10 of the tau gene and a widespread tau accumulation in the glial cells.

Iseki E., Matsumura T., Marui W. et al
2001, Acta Neuropathol. (102) 285-292

Pick's disease associated with the novel Tau gene mutation K369I.

Neumann M., Schulz-Schaeffer W., Crowther R.A. et al
2001, Ann. Neurol. (50) 503-513

Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.

Pastor P., Pastor E., Carnero C. et al
2001, Ann. Neurol. (49) 263-267

1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.

Wintjens R., Wieruszeski J.M., Drobecq H. et al
2001, J. Biol. Chem. (276) 25150-25156

Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene.

Arima K., Kowalska A., Hasegawa M. et al
2000, Neurology (54) 1787-1795

Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease.

Goedert M., Spillantini M.G.
2000, Biochim. Biophys. Acta (1502) 110-121

Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation.

Lippa C.F., Zhukareva V., Kawarai T. et al
2000, Ann. Neurol. (48) 850-858

Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments.

Maas T., Eidenmueller J., Brandt R. et al
2000, J. Biol. Chem. (275) 15733-15740

Pick's disease is associated with mutations in the tau gene.

Pickering-Brown S., Baker M., Yen S.-H. et al
2000, Ann. Neurol. (48) 859-867

Tau gene mutation K257T causes a tauopathy similar to Pick's disease.

Rizzini C., Goedert M., Hodges J.R. et al
2000, J. Neuropathol. Exp. Neurol. (59) 990-1001

A Japanese patient with frontotemporal dementia and parkinsonism by a tau P301S mutation.

Yasuda M., Yokoyama K., Nakayasu T. et al
2000, Neurology (55) 1224-1227

Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau.

Bugiani O., Murrell J.R., Giaccone G. et al
1999, J. Neuropathol. Exp. Neurol. (58) 667-677

A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.

Delisle M.-B., Murrell J.R., Richardson R. et al
1999, Acta Neuropathol. (98) 62-77

Mutational analysis of the tau gene in progressive supranuclear palsy.

Higgins J.J., Adler R.L., Loveless J.M. et al
1999, Neurology (53) 1421-1424

A distinct familial presenile dementia with a novel missense mutation in the tau gene.

Iijima M., Tabira T., Poorkaj P. et al
1999, NeuroReport (10) 497-501

Tau gene mutation G389R causes a tauopathy with abundant pick body- like inclusions and axonal deposits.

Murrell J.R., Spillantini M.G., Zolo P. et al
1999, J. Neuropathol. Exp. Neurol. (58) 1207-1226

Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.

Nacharaju P., Lewis J., Easson C. et al
1999, FEBS Lett. (447) 195-199

High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands.

Rizzu P., Van, Swieten J.C. et al
1999, Am. J. Hum. Genet. (64) 414-421

A mutation in the microtubule-associated protein tau in pallido- nigro-luysian degeneration.

Yasuda M., Kawamata T., Komure O. et al
1999, Neurology (53) 864-868

Pathogenic implications of mutations in the tau gene in pallido- ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.

Clark L.N., Poorkaj P., Wszolek Z. et al
1998, Proc. Natl. Acad. Sci. U.S.A. (95) 13103-13107

Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism.

Dumanchin C., Camuzat A., Campion D. et al
1998, Hum. Mol. Genet. (7) 1825-1829

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Hutton M., Lendon C.L., Rizzu P. et al
1998, Nature (393) 702-705

The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease.

Illenberger S., Zheng-Fischhofer Q., Preuss U. et al
1998, Mol. Biol. Cell (9) 1495-1512

Tau is a candidate gene for chromosome 17 frontotemporal dementia.

Poorkaj P., Bird T.D., Wijsman E. et al
1998, Ann. Neurol. (43) 815-825

Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.

Sengupta A., Kabat J., Novak M. et al
1998, Arch. Biochem. Biophys. (357) 299-309

Characterization of in vitro glycation sites of tau.

Nacharaju P., Ko L., Yen S.H. et al
1997, J. Neurochem. (69) 1709-1719

The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine.

Arnold C.S., Johnson G.V.W., Cole R.N. et al
1996, J. Biol. Chem. (271) 28741-28744

Molecular evolution of tau protein: implications for Alzheimer's disease.

Nelson P.T., Stefansson K., Gulcher J. et al
1996, J. Neurochem. (67) 1622-1632

Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.

Drewes G., Trinczek B., Illenberger S. et al
1995, J. Biol. Chem. (270) 7679-7688

Expression of three- and four-repeat tau isoforms in mouse liver.

Kenner L., el-Shabrawi Y., Hutter H. et al
1994, Hepatology (20) 1086-1089

Diversity of high-molecular-weight tau proteins in different regions of the nervous system.

Mavilia C., Couchie D., Nunez J. et al
1994, J. Neurochem. (63) 2300-2306

Complete sequence of 3'-untranslated region of tau from rat central nervous system. Implications for mRNA heterogeneity.

Sadot E., Marx R., Barg J. et al
1994, J. Mol. Biol. (241) 325-331

Molecular diversity at the carboxyl terminus of human and rat tau.

Sawa A., Oyama F., Matsushita M. et al
1994, Brain Res. Mol. Brain Res. (27) 111-117

High molecular weight tau proteins and acquisition of neuronal polarity in peripheral nervous system.

Couchie D., Gache Y., Mavilia C. et al
1993, C. R. Acad. Sci. III, Sci. Vie (316) 404-409

Expression of high molecular weight tau in the central and peripheral nervous systems.

Georgieff I.S., Liem R.K.H., Couchie D. et al
1993, J. Cell Sci. (105) 729-737

In vivo phosphorylation sites in fetal and adult rat tau.

Watanabe A., Hasegawa M., Suzuki M. et al
1993, J. Biol. Chem. (268) 25712-25717

Structure and novel exons of the human tau gene.

Andreadis A., Brown W.M., Kosik K.S. et al
1992, Biochemistry (31) 10626-10633

Primary structure of high molecular weight tau present in the peripheral nervous system.

Couchie D., Mavilia C., Georgieff I.S. et al
1992, Proc. Natl. Acad. Sci. U.S.A. (89) 4378-4381

Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system.

Goedert M., Spillantini M.G., Crowther R.A. et al
1992, Proc. Natl. Acad. Sci. U.S.A. (89) 1983-1987

Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain.

Hasegawa M., Morishima-Kawashima M., Takio K. et al
1992, J. Biol. Chem. (267) 17047-17054

Molecular characterization of microtubule-associated proteins tau and MAP2.

Goedert M., Crowther R.A., Garner C.C. et al
1991, Trends Neurosci. (14) 193-199

Identification of 3- and 4-repeat tau isoforms within the PHF in Alzheimer's disease.

Jakes R., Novak M., Davison M. et al
1991, EMBO J. (10) 2725-2729

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Goedert M., Spillantini M.G., Jakes R. et al
1989, Neuron (3) 519-526

Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain.

Goedert M., Spillantini M.G., Potier M.C. et al
1989, EMBO J. (8) 393-399

Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family.

Himmler A.
1989, Mol. Cell. Biol. (9) 1389-1396

Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains.

Himmler A., Drechsel D., Kirschner M.W. et al
1989, Mol. Cell. Biol. (9) 1381-1388

Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA.

Kanai Y., Takemura R., Oshima T. et al
1989, J. Cell Biol. (109) 1173-1184

Developmentally regulated expression of specific tau sequences.

Kosik K.S., Orecchio L.D., Bakalis S. et al
1989, Neuron (2) 1389-1397

The microtubule binding domain of tau protein.

Lee G., Neve R.L., Kosik K.S. et al
1989, Neuron (2) 1615-1624

A distinct form of tau is selectively incorporated into Alzheimer's paired helical filaments.

Mori H., Hamada Y., Kawaguchi M. et al
1989, Biochem. Biophys. Res. Commun. (159) 1221-1226

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Goedert M., Wischik C., Crowther R. et al
1988, Proc. Natl. Acad. Sci. U.S.A. (85) 4051-4055

The primary structure and heterogeneity of tau protein from mouse brain.

Lee G., Cowan N.J., Kirschner M. et al
1988, Science (239) 285-288